Nagendra K. Chaturvedi

Chronic Lymphocytic Leukemia Cells in a Lymph Node Microenvironment Depict Molecular Signature Associated with an Aggressive Disease

Amit Mittal, Nagendra K. Chaturvedi, Christine E. Gilling-Cutucache et al. · Molecular Medicine · 2014 · 68 citations · Full text

Lymphocyte Development, Mixed-phenotype Acute Leukemia, Immunology +22

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia

Amit Mittal, Nagendra K. Chaturvedi, Rae A. Rohlfsen et al. · PLoS ONE · 2013 · 50 citations · Full text

Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy

Nagendra K. Chaturvedi, Matthew J. Kling, Donald W. Coulter et al. · Oncotarget · 2018 · 42 citations · Full text

Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders

Nagendra K. Chaturvedi, Sanjay Kumar, Seema Negi et al. · Molecular and Cellular Biochemistry · 2010 · 41 citations

Metabolic Syndrome, Androgen Receptor, Endocrine Disruptors +11

Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells

Yu-Wei Chou, Nagendra K. Chaturvedi, Shougiang Ouyang et al. · Cancer Letters · 2011 · 40 citations

Urology, Oncology, Medicine +7